全文获取类型
收费全文 | 10640篇 |
免费 | 980篇 |
国内免费 | 864篇 |
专业分类
耳鼻咽喉 | 87篇 |
儿科学 | 114篇 |
妇产科学 | 142篇 |
基础医学 | 1295篇 |
口腔科学 | 121篇 |
临床医学 | 1402篇 |
内科学 | 1586篇 |
皮肤病学 | 125篇 |
神经病学 | 584篇 |
特种医学 | 373篇 |
外国民族医学 | 10篇 |
外科学 | 994篇 |
综合类 | 1734篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 752篇 |
眼科学 | 469篇 |
药学 | 1126篇 |
7篇 | |
中国医学 | 594篇 |
肿瘤学 | 964篇 |
出版年
2024年 | 30篇 |
2023年 | 152篇 |
2022年 | 427篇 |
2021年 | 542篇 |
2020年 | 388篇 |
2019年 | 363篇 |
2018年 | 398篇 |
2017年 | 333篇 |
2016年 | 338篇 |
2015年 | 478篇 |
2014年 | 585篇 |
2013年 | 527篇 |
2012年 | 818篇 |
2011年 | 926篇 |
2010年 | 611篇 |
2009年 | 433篇 |
2008年 | 635篇 |
2007年 | 535篇 |
2006年 | 527篇 |
2005年 | 558篇 |
2004年 | 346篇 |
2003年 | 305篇 |
2002年 | 257篇 |
2001年 | 221篇 |
2000年 | 286篇 |
1999年 | 268篇 |
1998年 | 171篇 |
1997年 | 139篇 |
1996年 | 145篇 |
1995年 | 107篇 |
1994年 | 94篇 |
1993年 | 55篇 |
1992年 | 71篇 |
1991年 | 64篇 |
1990年 | 73篇 |
1989年 | 41篇 |
1988年 | 43篇 |
1987年 | 38篇 |
1986年 | 34篇 |
1985年 | 26篇 |
1984年 | 13篇 |
1983年 | 9篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1974年 | 6篇 |
1973年 | 9篇 |
1972年 | 5篇 |
1970年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
99Tcm-MIBI显像评价乳腺癌新辅助化疗疗效 总被引:2,自引:1,他引:1
目的 探讨^99Tc^m-甲氧基异丁基异腈(MIBI)显像评价乳腺癌新辅助化疗(NCT)疗效的价值。方法 35例局部进展期乳腺癌(LABC)患者术前化疗前后分别触诊估测肿瘤最大垂直长径及行^99Tc^m-MIBI显像,术后对乳腺癌标本行病理检查及P-糖蛋白(P-gP)、增殖细胞核抗原(PCNA)免疫组织化学染色。观察注射^99Tc^m-MIBI后60min显像图。采用目测法和半定量法,以病灶/本底(T/N)放射性比值降低〉35%为有效。临床疗效按WHO标准评价。化疗后肿瘤细胞病理形态学改变以Ⅱ、Ⅲ级定为显效,Ⅰ级定为弱效。结果 病理检查显效与弱效组间,显像目测法分析NCT有效率分别为75%和9%,差异有显著性(P〈0.01),灵敏度、特异性和准确性分别为75%、91%和80%;半定量法评价NCT疗效的灵敏度、特异性和准确性分别为84%、80%和83%;临床测量肿瘤最大垂直长径则分别为50%、64%和54%。^99Tc^m-MIBI显像评价疗效的灵敏度、准确性明显高于临床确诊。24例病理检查示显效的患者中,^99Tc^m-MIBI摄取与PCNA水平相关,与P-gP水平无关。结论 ^99Tc^m-MIBI显像可有效监测LABC患者术前NCT疗效。 相似文献
22.
BACKGROUND: Dendritic cell is the most major antigen presenting cell of organism. It is proved in recent studies that human umbilical cord blood mononuclear cells induced and cultured in vitro by recombinant human granulocyte-macrophage colony stimulating factor (rhG-MCSF) and recombinant human interleukin-4(rhIL-4) can generate a great many dendritic cells and promote the lethal effect of T cells on human neuroblastoma, but it is unclear that whether the lethal effect is associated with the most proper concentration of dendritic cells.
OBJECTIVE: To investigate the lethal effect of human umbilical cord blood mononuclear cells induced in vitro by cytokines differentiating into dendritic cells on human neuroblastoma, and its best concentration range.
DESIGN: Open experiment.
SETTING: Department of Pediatrics, the Medical School Hospital of Qingdao University.
MATERIALS: The study was carried out in the Shandong Provincial Key Laboratory (Laboratory for the Department of Pediatrics of the Medical School Hospital of Qingdao University) during September 2005 to May 2006. Human umbilical cord blood samples were taken from the healthy newborn infants of full-term normal delivery during October to November 2005 in the Medical School Hospital of Qingdao University, and were voluntarily donated by the puerperas. Main instruments: type 3111 CO2 incubator (Forma Scientific, USA), type 550 ELISA Reader (Bio-Rad, USA). Main reagents: neuroblastoma cell line SK-N-SH (Shanghai Institute of Life Science, Chinese Academy of Sciences), RPMI-1640 culture fluid and fetal bovine serum (Hyclone), rhIL-4 (Promega, USA), rhG-MCSF (Harbin Pharmaceutic Group Bioengineering Co.Ltd), rat anti-human CD1a monoclonal antibody and FITC-labeled rabbit anti-rat IgG (Xiehe Stem cell Gene Engineering Co.Ltd).
METHODS: ① Human umbilical cord blood mononuclear cells obtained with attachment methods differentiated into human umbilical cord blood dendritic cells, presenting typical morphology of dendritic cells after in vitro induction by rhG-MCSF and rhIL-4. ② Different concentrations of dendritic cells[ dendritic cells: neuroblastoma cells=20∶1,50∶1,100∶1(2×108 L-1,5×108 L-1,1×109 L-1)], 1×109 L-1 T cells and 1×107 L-1 neuroblastoma cells were added in the experimental group. 1×109 L-1 T cells and 1×107 L-1 neuroblastoma cells were added in the control group. ③ Main surface marker CD1a molecules of dendritic cells were detected with indirect immunofluorescence, and the percent rate of dendritic cells was counted with ultraviolet light and expressed as the expression rate of CD1a+ cells. ④ Single effector cells and target cells were respectively set in the experimental group and control group to obtain the lethal effect. The lethal effect of dendritic cells on neuroblastoma cells was indirectly evaluated by detecting cellular survival with MTT assay. The lethal effect(%)=(1-A experimental well-A effector cell well/A target cell well)×100%.⑤The experimental data were presented as Mean ±SD, and paired t test was used.
MAIN OUTCOME MEASURES: ① Morphological characters of dendritic cells in the process of induction and differentiation. ②CD1a+ cellular expression rate. ③Lethal effect of dendritic cells on neuroblastoma cells.
RESULTS: ①Morphological characters of dendritic cells in the process of induction and differentiation: On the 15th day after human umbilical cord blood mononuclear cells were induced by rhG-MCSF and rhIL-4, typical morphology of dendritic cells could be seen under an inverted microscope. ②Expression rate of CD1a+ cells was (43.12±5.83)%. ③Lethal effect of dendritic cells on neuroblastoma cells: Lethal effect of dendritic cells stimulated T cells in each experimental group ( dendritic cells: neuroblastoma cells=100∶1,50∶1,20∶1 respectively) on neuroblastoma cells was significantly higher than that in control group[(31.00 ±4.41)%,(30.92±5.27)%,(33.57±5.35)%,(26.23±5.20)%, t=3.51,2.98,4.24, P < 0.01); But the lethal effect of dendritic cells on neuroblastoma was significantly lower when their ratio was 100∶1 and 50∶1 in comparison with 20:1 (t=2.01,2.36, P < 0.05), and no significant difference in lethal effect existed between the ratio at 100∶1 and 50∶1(t=0.06,P > 0.05).
CONCLUSION: Dendritic cells differentiated from human umbilical cord blood mononuclear cells after in vitro induction of cytokines can promote the lethal effect of T cells on neuroblastoma cells. The lethal effect is associated with the concentration of dendritic cells within some range. 相似文献
23.
24.
25.
26.
27.
对6例原发性膀胱腺癌进行临床病理分析,患者年龄40~76岁,男4例,女2例。术前病程多为2个月,以血尿症状为主。6例均经病理检查证实,其中4例加做PAS染色,证实有PAS阳性物质,免疫组化标记CEA4例,有3例呈阳性结果。本组随访结果5例死亡,存活时间9~43月,1例尚存活13月。结合文献着重讨论了影响膀胱腺癌预后诸因素。 相似文献
28.
致倦库蚊有机磷抗性相关扩增酯酶B基因的多样性 总被引:5,自引:0,他引:5
本实验从佛山和成都两地的致倦库蚊群体中筛选出3个酯酶类型不同的有机磷(OP)抗性品系,FS-1、FS-2和CD-1品系。各品系的酯酶基因B扩增水平、酯酶活性和OP抗性水平三者一致。各品系酯酶B基因限制性酶切片段比较分析表明,我国的OP抗生库蚊群体中不仅有世界性分布的酯酶B1和B2,而且在佛山和成都地区各有一个新的独立扩增的酯酶B,分别命名为B6和B7。 相似文献
29.
对我院45例确诊为中、重度细菌感染住院患者进行了亚胺培南/西司他丁与头孢他啶疗效费用分析比较研究。结果表明:2组病例有效率、死亡率无显著性差异;头孢他啶组较亚胺培南/西司他丁组疗程明显延长。亚胺培南/西司他丁每日所需费用明显高于头孢他啶;治疗结束时,前者全部费用并未超过后者;全部住院费用无明显差异。作者认为:决定2种药物全部费用的因素,除与药物单价和每日费用有关,还与药物疗程密切相关。选用药物抗菌作用越强,用药时间即相应缩短,住院时间必然缩短;最终患者住院费用降低 相似文献
30.
回顾分析 65例脑脊液鼻漏病例。随访 3个月~ 1 0年 ,其中 2 6例经保守治疗痊愈 ,治愈率 40 %。 3 9例经保守治疗无效的患者 9例自动离院 ;行开颅手术修补 7例 ,其中 3例治愈 ;行鼻外入路修补术 3例 ,全部治愈 ;经鼻内镜修补术 2 0例 ,其中 1次手术治愈 1 9例 ,2次手术治愈 1例。经鼻内镜脑脊液鼻漏修补术的成功率为 1 0 0 % ,其中 1次修补成功率为 95 %。结果提示 :鼻内镜下脑脊液鼻漏修补术是外科治疗脑脊液鼻漏的首选术式 相似文献